By Nigam Arora & Dr. Natasha Arora The Arora Report typically gives target zones with the buy signals.  The first target zone for Ocugen (OCGN) was $7.73 to $8.31.   The stock hit $8 before pulling back. Per the system, all subscribers should have taken full profits and exited the position or taken partial profits.  Those who were willing to take the risk for the stock to hit the second target zone would have left a small quantity.  Such quantity should have been sold per the system when the stock continued pulling back. The prior buy zone is no longer valid

By Nigam Arora & Dr. Natasha Arora Editor’s note: In this stock market, there are many opportunities to make significant money not based on fundamentals but with short term trades based on the known behavior of the momo crowd.  Investors should consider taking advantage of such opportunities in addition to long term investments. The Arora Report provides many such opportunities in addition to the very long term Core Model Portfolio. This post was just published in ZYX Buy Change Alert. A NEW IDEA ON COVID VACCINE COMPANY OCGN Ocugen (OCGN) has a license from an Indian vaccine maker to get